Sandbox:farnaz: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) |
No edit summary |
||
| Line 17: | Line 17: | ||
*B-interferon | *B-interferon | ||
*Teleflunomide | *Teleflunomide | ||
96 patients (174 eyes, 70% females) were included with a mean age at presentation of 30 years | |||
{| class="wikitable" | {| class="wikitable" | ||
!align="center" style="background:#4479BA; color: #FFFFFF;" |Cause | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Cause | ||
!align="center" style="background:#4479BA; color: #FFFFFF;" |Symptom | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Symptom | ||
!align="center" style="background:#4479BA; color: #FFFFFF;" |Diagnosis | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Diagnosis | ||
!align="center" style="background:#4479BA; color: #FFFFFF;" |Treatment | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Treatment | ||
|- | |- | ||
|1 | |1 | ||
| Line 41: | Line 44: | ||
==References== | ==References== | ||
<references /> | |||
Revision as of 21:27, 26 January 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farnaz Khalighinejad, MD [2]
Overview
MS is known as multiple sclerosis.
Multiple Sclerosis
ajksfshvanivlk
Type 1:
asdad
Type 2:
The primary therapy for MS may include:[1][2]
- B-interferon
- Teleflunomide
96 patients (174 eyes, 70% females) were included with a mean age at presentation of 30 years
| Cause | Symptom | Diagnosis | Treatment |
|---|---|---|---|
| 1 | |||
| 2 | |||
| 3 |
References
- ↑ Kamm CP, Uitdehaag BM, Polman CH (2014). "Multiple sclerosis: current knowledge and future outlook". Eur Neurol. 72 (3–4): 132–41. doi:10.1159/000360528. PMID 25095894.
- ↑ Schwartz K, Wymbs NF, Huang H, Mealy MA, Pardo CA, Zackowski K; et al. (2017). "Randomized, Placebo-controlled Crossover Study of Dalfampridine Extended-release in Transverse Myelitis". Mult Scler J Exp Transl Clin. 3 (4): 2055217317740145. doi:10.1177/2055217317740145. PMC 5731631. PMID 29270309.